Combination therapy with long-acting β-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects

    Research output: Contribution to journalComment/debate

    Original languageEnglish
    Pages (from-to)78-79
    Number of pages2
    JournalEvidence-Based Medicine
    Volume15
    Issue number3
    DOIs
    Publication statusPublished - Jun 2010

    Cite this